Sen Li

Mr. Sen Li

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2020 in Multimedia Tools and Applications
Verified
Journal Article
Closed access
PDF file
Xinyu ZhangXinyu Zhang
Xinyu Zhang
SLSen Li
Sen Li
XJXiaoyuan Jing
Xiaoyuan Jing
FMFei Ma
Fei Ma
CZChen Zhu
Chen Zhu

5 March 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
SLSen Li
Sen Li
ALAijia Li
Aijia Li
DLDiego Alejandro Molina Lara
Diego Alejandro Molina Lara
JMJorge Enrique Gómez Marín
Jorge Enrique Gómez Marín
MJMario Juhas
Mario Juhas
YZYang Zhang
Yang Zhang
Toxoplasma gondii , one of the world’s most common parasites, can infect all types of warm-blooded animals, including one-third of the world’s human population. Most current routine diagnostic methods are costly, time-consuming, and labor-intensive. Although T.gondii can be directly observed under the microscope in tissue or spinal fluid samples, this form of identification is difficult and requires well trained professionals. Nevertheless, the traditional identification of parasites under the microscope is still performed by a large number of laboratories. Novel, efficient and reliable methods of T.gondii identification are therefore needed, particularly in developing countries. To this end, we developed a novel transfer learning based microscopic image recognition method for T.gondii identification. This approach employs Fuzzy Cycle Generative Adversarial Network (FCGAN) with transfer learning utilizing knowledge gained by the parasitologists that Toxoplasma is in banana or crescent shaped form. Our approach aims to build connection between micro and macro associated objects by embedding fuzzy C-means cluster algorithm into Cycle Generative Adversarial Network (Cycle GAN). Our approach achieves 93.1% and 94.0% detection accuracy for 400X and 1000X Toxoplasma microscopic images respectively. We show the high accuracy and effectiveness of our approach in the newly collected unlabeled Toxoplasma microscopic images, comparing to other current available deep learning methods. This novel method for Toxoplasma microscopic image recognition will open a new window for developing cost-effective and scalable deep learning based diagnostic solution, potentially enabling broader clinical access in developing countries.

2 September 2026 in Cancer Immunology, Immunotherapy
Verified
Journal Article
Open access
PDF file
JLJiayu Liu
Jiayu Liu
TLTongtan Liu
Tongtan Liu
YWYuxin Wang
Yuxin Wang
BGBaorui Guo
Baorui Guo
ZGZhao Gao
Zhao Gao
JZJianning Zhang
Jianning Zhang
Glioblastoma remains one of the most lethal primary malignant brain tumors, and immunotherapy has produced limited clinical benefit despite major success in other cancers. This resistance reflects spatial and molecular heterogeneity, myeloid-dominant immune suppression, restricted lymphocyte infiltration, antigenic instability, blood–brain barrier-related constraints, corticosteroid exposure, and treatment-induced immune remodeling. Conventional preclinical models only partially reproduce these features, limiting their ability to predict patient-specific immunotherapy responses. Patient-derived glioblastoma organoids (GBOs) have emerged as experimentally tractable platforms that can preserve key features of parental tumors while enabling functional therapeutic testing. In this review, we discuss the rationale, technical evolution, applications, and translational challenges of GBOs in immuno-oncology, including tumor-immune modeling, checkpoint blockade, cellular therapies, myeloid modulation, vaccines, oncolytic virotherapy, multi-omic readouts, and artificial intelligence-assisted analysis. We place particular emphasis on oncolytic herpes simplex virus-based strategies and on the ability of GBOs to evaluate viral entry, replication, spatial spread, innate antiviral restriction, immunogenic cell death, and rational combinations. Finally, we outline staged, clinically integrated workflows while emphasizing immune-cell attrition, incomplete microenvironmental fidelity, resource requirements, and the need for prospective validation in small exploratory trials.